Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is PREGABALIN, with a corresponding US DMF Number 30273.
Remarkably, this DMF maintains an Active status since its submission on May 27, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 08, 2016, and payment made on May 25, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II